Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest research
Our research can still be accessed for free under MIFID II.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax enhanced research
- VCT
- EIS
- SEIS
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Burford Capital
Financials
Equity issue ensures growth is not adjourned
By
Dr Brian Moretta
05 Oct 2018
Building & Construction
UK Housebuilding Sector in 3Q 2018……trains, cows and beyond
By
Tony Williams
05 Oct 2018
Warpaint London
Consumer
1H’18 interims: delivering the results
By
Yingheng Chen
04 Oct 2018
Diurnal Group Plc
Life Sciences
First commercial revenues
By
Dr Martin Hall
04 Oct 2018
The Monthly: October 2018
03 Oct 2018
Redx Pharma
Life Sciences
Strategy launch
By
Dr Martin Hall
02 Oct 2018
Palace Capital
Property
Initiation of coverage
By
Mike Foster
28 Sep 2018
Allergy Therapeutics plc
Life Sciences
2018 full-year results: solid growth
By
Dr Martin Hall
27 Sep 2018
Haydale Graphene Industries Plc
Industrial
Exuberance, reality; enlightenment now to follow
By
Paul Singer
26 Sep 2018
Oxford BioMedica
Life Sciences
Partnering strategy delivering profitability
By
Dr Dorothea Hill
20 Sep 2018
City of London Investment Group
Financials
Strengthening cash position to boost returns
By
Dr Brian Moretta
20 Sep 2018
Prev
1
...
32
33
34
35
36
...
52
Next
